logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Close, Michael Stuart
    Born in April 1971
    Individual (10 offsprings)
    Officer
    2018-06-18 ~ now
    OF - Director → CIF 0
    Mr Michael Stuart Close
    Born in April 1971
    Individual (10 offsprings)
    Person with significant control
    2018-06-18 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

LOGIXX PHARMA HOLDING GROUP LIMITED

Period: 2018-06-18 ~ now
Company number: 11419134
Registered name
LOGIXX PHARMA HOLDING GROUP LIMITED - now
Standard Industrial Classification
99999 - Dormant Company
Brief company account
Average Number of Employees
02023-07-01 ~ 2024-06-30
02022-07-01 ~ 2023-06-30
Par Value of Share
Class 1 ordinary share
12023-07-01 ~ 2024-06-30
Fixed Assets - Investments
578,875 GBP2024-06-30
578,875 GBP2023-06-30
Creditors
Current
577,875 GBP2024-06-30
577,875 GBP2023-06-30
Net Current Assets/Liabilities
-577,875 GBP2024-06-30
-577,875 GBP2023-06-30
Total Assets Less Current Liabilities
1,000 GBP2024-06-30
1,000 GBP2023-06-30
Equity
Called up share capital
1,000 GBP2024-06-30
1,000 GBP2023-06-30
Equity
1,000 GBP2024-06-30
1,000 GBP2023-06-30
Investments in Group Undertakings
Cost valuation
578,875 GBP2023-06-30
Investments in Group Undertakings
578,875 GBP2024-06-30
578,875 GBP2023-06-30
Amounts owed to group undertakings
Current
577,875 GBP2024-06-30
577,875 GBP2023-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000 shares2024-06-30
Nominal value of allotted share capital
1,000 GBP2023-07-01 ~ 2024-06-30
1,000 GBP2022-07-01 ~ 2023-06-30

Related profiles found in government register
  • LOGIXX PHARMA HOLDING GROUP LIMITED
    Info
    Registered number 11419134
    Merlin House Brunel Road, Theale, Reading, Berkshire RG7 4AB
    PRIVATE LIMITED COMPANY incorporated on 2018-06-18 (7 years 11 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-06-17
    CIF 0
  • LOGIXX PHARMA HOLDING GROUP LIMITED
    S
    Registered number 11419134
    Merlin House, Brunel Road, Theale, Reading, Berkshire, England, RG7 4AB
    Private Limited Company in England And Wales
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    LOGIXX PHARMA LIMITED
    - now 07209211
    LOGIXX PHARMA SOLUTIONS LIMITED
    - 2020-01-09 07209211
    Merlin House Brunel Road, Theale, Reading, Berkshire, England
    Active Corporate (4 parents)
    Person with significant control
    2018-07-11 ~ now
    CIF 1 - Ownership of shares – 75% or more OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.